Stocksigma LogoStocksigma Logo

Aakaar Medical Technologies Posts Strong H1FY27 Turnaround; Grants ESOPs

Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lakh for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49

Aakaar Medical Technologies Posts Strong H1FY27 Turnaround; Grants ESOPs

Aakaar Medical Technologies Ltd · Outcome · 31 Oct 2026, 12:06 am

Aakaar Medical Technologies Posts Strong H1FY27 Turnaround; Grants ESOPs Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lakh for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49 lakh. The company turned profitable with a net profit of ₹354.09 lakh compared to a net loss of ₹78.41 lakh in H1FY26, driving basic EPS to ₹2.50 versus negative ₹0.63. Additionally, the board approved granting 186,720 ESOPs at an exercise price of ₹10 and cleared the appointment of Abhash Dilip Meswani as Whole-time Director for five years, subject to shareholder approval.

Original exchange filing (PDF)

More announcements from Aakaar Medical Technologies Ltd

All Aakaar Medical Technologies Ltd announcements